Finance

Lists
Q3 2026 earnings • released • EPS beat +14.91% • Revenue beat +1.43%
See results
INMD:NASDAQ
Inmode Ltd
$13.73
+3.51%
(+0.46) 1D
$13.73
0.00% (0.00)
After hours
Closed: Nov 11, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INMD...
Open
$13.81
High
$13.90
Low
$13.28
Mkt. cap
790.08M
Avg. vol.
537.46K
Volume
0.00
P/E ratio
11.17
52-wk high
$16.67
52-wk low
$12.72
EPS
$1.23
Beta
1.98
Shares outstanding
57.48M
No. of employees
660
Open
$13.81
High
$13.90
Low
$13.28
Mkt. cap
790.08M
Avg. vol.
537.46K
Volume
0.00
P/E ratio
11.17
52-wk high
$16.67
52-wk low
$12.72
EPS
$1.23
Beta
1.98
Shares outstanding
57.48M
No. of employees
660
News stories
From web sources and news partners
About Inmode Ltd
CEOMoshe Mizrahy
Employees660
Founded2008
Headquarters-
SectorHealth Care
IndustryMedical device
Websiteinmodemd.com
Analyst ratings
Based on 2 analysts giving stock ratings to INMD in the past 3 months
Hold
Buy
0
Hold
2
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for INMD in the last 3 months.
Highest
Current $13.73
$15.00 (+9.25%)
Average
$15.00 (+9.25%)
Lowest
$15.00 (+9.25%)
Analyst
Recommendation
Action
Price target
Projected
Date
Caitlin Roberts
Canaccord Genuity
Hold
Reiterated
$15.00
+9.2%
10/14/2026
Sam Eiber
BTIG
Hold
Maintained
-
-
10/13/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/05/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
$17.00
+23.8%
07/14/2026
Matt Miksic
Barclays
Buy
Maintained
$19.00
+38.4%
05/07/2026
Unknown Analyst
Jefferies
Hold
Reiterated
$15.00
+9.2%
04/14/2026
Last report
Nov 11, 2026
Fiscal period
Q3 2026
$0.37 / $0.32
+14.91%beat
Revenue / Est. (USD)
92.14M / 90.84M
+1.43%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
93.16M
103.85M
82.02M
95.59M
Cost of goods sold
20.86M
22.55M
20.46M
24.07M
Cost of revenue
20.86M
22.55M
20.46M
24.07M
Research and development expenses
3.54M
3.51M
3.54M
3.66M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
47.87M
51.80M
47.95M
55.60M
Operating expense
51.41M
55.31M
51.50M
59.26M
Total operating expenses
72.27M
77.86M
71.96M
83.33M
Operating income
20.90M
25.99M
10.06M
12.26M
Other non operating income
-
3.38M
-
-
EBT including unusual items
25.62M
31.29M
14.35M
19.69M
EBT excluding unusual items
25.62M
31.31M
14.35M
19.69M
Income tax expense
3.76M
4.27M
2.79M
2.62M
Effective tax rate
14.66%
13.64%
19.44%
13.33%
Other operating expenses
-
-
-
-
Net income
21.86M
27.02M
11.56M
17.06M
Net profit margin
23.47%
26.02%
14.10%
17.85%
Earnings per share
0.38
0.46
0.25
0.35
Interest and investment income
4.72M
1.94M
4.30M
7.43M
Interest expense
-
-
-
-
Net interest expenses
4.72M
1.94M
4.30M
7.43M
Depreciation and amortization charges
-
-
-
-
EBITDA
21.05M
26.16M
10.23M
12.44M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps